Clinical Trials Directory

Trials / Conditions / Facioscapulohumeral Muscular Dystrophy (FSHD)

Facioscapulohumeral Muscular Dystrophy (FSHD)

7 registered clinical trials studyying Facioscapulohumeral Muscular Dystrophy (FSHD) — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingBetterLife FSHD: A Patient-driven Health and Research Platform
NCT07409142
FSHD Society—
Active Not RecruitingA Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy
NCT05548556
Hoffmann-La RochePhase 2
TerminatedEfficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
NCT05397470
Fulcrum TherapeuticsPhase 3
TerminatedEfficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With
NCT04264442
Fulcrum TherapeuticsPhase 2
CompletedEfficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD)
NCT04003974
Fulcrum TherapeuticsPhase 2
CompletedEvaluate Safety and Biological Activity of ATYR1940 in Participants With Early Onset Facioscapulohumeral Muscu
NCT02603562
aTyr Pharma, Inc.Phase 1 / Phase 2
CompletedSafety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Participants With Muscula
NCT02239224
aTyr Pharma, Inc.Phase 1 / Phase 2